An Open-label, Randomized and Crossover Study to Assess the Effect of Co-administration of Vildagliptin and Voglibose on the Steady-state Pharmacokinetics / Pharmacodynamics in Japanese Patients With Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 19 Jun 2013
At a glance
- Drugs Vildagliptin; Voglibose
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novartis Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 11 Oct 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
- 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.